(Q44936405)

7 December 2017

0 references

Strategies for successful vaccination against hepatocellular carcinoma (English)

1 reference

7 December 2017

M Rinaldi

1

1 reference

7 December 2017

S Iurescia

2

1 reference

7 December 2017

D Fioretti

3

1 reference

7 December 2017

A Ponzetto

4

1 reference

7 December 2017

G Carloni

5

1 reference

7 December 2017

publication date

1 April 2009

1 reference

International Journal of Immunopathology and Pharmacology

7 December 2017

published in

1 reference

7 December 2017

volume

22

1 reference

7 December 2017

issue

2

1 reference

7 December 2017

page(s)

269-277

1 reference

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

7 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200203

Recurrence rate and transplantability after liver resection in patients with hepatocellular carcinoma who initially met transplantation criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200203

Two cases of spontaneous regression of multicentric hepatocellular carcinoma after intraperitoneal rupture: possible role of immune mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200203

Induction of autologous tumor-specific cytotoxic T cells in patients with liver cancer. Characterizations and clinical utilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200203

Tumor Immunity Produced by the Intradermal Inoculation of Living Tumor Cells and Living Mycobacterium bovis (Strain BCG)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200203

Immunotherapeutic strategies for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200203

Carcinoembryonic antigen (CEA) presentation and specific T cell-priming by human dendritic cells transfected with CEA-mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200203

Identification of HLA-A2- or HLA-A24-restricted CTL epitopes possibly useful for glypican-3-specific immunotherapy of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200203

Wilms' tumour 1 gene expression is increased in hepatocellular carcinoma and associated with poor prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200203

Spontaneous tumor-specific humoral and cellular immune responses to NY-ESO-1 in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200203

Ex vivo characterization of tumor-derived melanoma antigen encoding gene-specific CD8+cells in patients with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200203

DNA vaccination with AFP-encoding plasmid DNA prevents growth of subcutaneous AFP-expressing tumors and does not interfere with liver regeneration in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200203

T cell responses to HLA-A*0201-restricted peptides derived from human alpha fetoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200203

Hierarchy of alpha fetoprotein (AFP)-specific T cell responses in subjects with AFP-positive hepatocellular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200203

Vaccination of fusion cells of rat dendritic and carcinoma cells prevents tumor growth in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200203

Construction and expression of recombined human AFP eukaryotic expression vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200203

NKT and CD8 lymphocytes mediate suppression of hepatocellular carcinoma growth via tumor antigen-pulsed dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200203

Induction of Polyclonal Prostate Cancer-Specific CTL Using Dendritic Cells Transfected with Amplified Tumor RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200203

Induction of alpha-fetoprotein-specific CD4- and CD8-mediated T-cell response using RNA-transfected dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200203

alpha-fetoprotein and interleukin-18 gene-modified dendritic cells effectively stimulate specific type-1 CD4- and CD8-mediated T-Cell response from hepatocellular carcinoma patients in Vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200203

A DNA vaccine against chimeric AFP enhanced by HSP70 suppresses growth of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200203

Therapy of cancer by cytokines mediated by gene therapy approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200203

Prevention of hepatocellular carcinoma in mice by IL-2 and B7-1 genes co-transfected liver cancer cell vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200203

Adoptive transfer of TRAIL-expressing natural killer cells prevents recurrence of hepatocellular carcinoma after partial hepatectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200203

E1B-55K-deleted adenovirus expressing E1A-13S by AFP-enhancer/promoter is capable of highly specific replication in AFP-producing hepatocellular carcinoma and eradication of established tumor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200203

Gene therapy for hepatocellular carcinoma using non-viral vectors composed of bis guanidinium-tren-cholesterol and plasmids encoding the tissue inhibitors of metalloproteinases TIMP-2 and TIMP-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200203

Gene-based vaccines: recent technical and clinical advances

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200203

Immune response at birth, long-term immune memory and 2 years follow-up after in-utero anti-HBV DNA immunization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200203

Feasibilty of in utero DNA vaccination following naked gene transfer into pig fetal muscle: transgene expression, immunity and safety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200203

Minimally invasive treatment combined with cytokine-induced killer cells therapy lower the short-term recurrence rates of hepatocellular carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200203

In vitro generation of cytotoxic and regulatory T cells by fusions of human dendritic cells and hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200203

Induction of immunosuppressive molecules and regulatory T cells counteracts the antitumor effect of interleukin-12-based gene therapy in a transgenic mouse model of liver cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200203

Immunotherapy of murine hepatocellular carcinoma by alpha-fetoprotein DNA vaccination combined with adenovirus-mediated chemokine and cytokine expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463200902200203

10.1177/039463200902200203

21 January 2018

Identifiers

DOI

1 reference

release_2eg3kfvcdbeu5ky74mru4cetqy

7 December 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/2eg3kfvcdbeu5ky74mru4cetqy

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference